Topic: Pfizer Inc.

Pfizer's Lyrica helps in restless legs syndrome study

(Reuters) - Pfizer Inc's Lyrica pain treatment benefited patients with Restless Legs Syndrome in a late-stage clinical study, the company said on Friday.The Phase III study of more than 700 patients met its three main goals, Pfizer said.Restless Legs Syndrome is an ...

diphenhydramine

5 mg/kg daily or 150 mg/m2 daily (up to a maximum of 300 mg daily) divided in 4 doses.. 25-50 mg every 4-6 hours (as diphenhydramine hydrochloride) or 38 mg every 4 hours (as diphenhydramine citrate); do not exceed 300 mg (as ...